Pemafibrate Uses, Dosage, Side Effects and more
Pemafibrate is under investigation in clinical trial NCT03350165 (A Study of Pemafibrate in Patients With Nonalcoholic Fatty Liver Disease (NAFLD)).
| Trade Name | Pemafibrate |
| Generic | Pemafibrate |
| Pemafibrate Other Names | Pemafibrate |
| Type | |
| Formula | C28H30N2O6 |
| Weight | Average: 490.556 Monoisotopic: 490.210386694 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
